Prediction of mizoribine pharmacokinetic parameters by serum creatinine in renal transplant recipients

被引:3
|
作者
Chen, Pan [1 ]
Xu, Xuan [1 ]
Liu, Longshan [2 ]
Wu, Jingjing [1 ]
Li, Jingjie [3 ]
Fu, Qian [2 ]
Chen, Jie [1 ]
Wang, Changxi [2 ]
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Pharm, 58 Zhong Shan Er Lu, Guangzhou, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Affiliated Hosp 1, Organ Transplantat Ctr, 58 Zhong Shan Er Lu, Guangzhou, Guangdong, Peoples R China
[3] Sun Yat Sen Univ, Affiliated Hosp 6, Ctr Reprod Med, Guangzhou, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
Mizoribine; Renal transplantation; Pharmacokinetics; Immunosuppression; HIGH-DOSE MIZORIBINE; MYCOPHENOLATE-MOFETIL; BLOOD-LEVEL; BIOAVAILABILITY; BREDININ; SAFETY;
D O I
10.1007/s00228-018-2584-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
PurposeMizoribine (MZR) is an immunosuppressive agent with extensive inter-individual differences in pharmacokinetics (PK). Here, we investigated the PK characteristics of MZR in renal transplant recipients and gave equations for prediction of some critical PK parameters.MethodsA total of 40 renal transplant recipients participated in this prospective study and were administered MZR orally twice daily in the range of 1.1-8.9mgkg(-1)day(-1). Steady-state concentrations of MZR were detected before (0h) and 0.5, 1, 2, 3, 4, 5, 6, 8, and 12h after administration by high-performance liquid chromatography method. Another 38 patients with newly detected trough concentration (C-0) were enrolled to validate the obtained C-0 predictive equation.ResultsSignificant inter-individual differences in MZR PK parameters were observed. Patients with decreasing creatinine clearance rate (CCr) had significantly decreased terminal elimination rate constant (k(el)) and apparent total body clearance (Cl/F), while other PK parameters including apparent terminal half-life (t(1/2)), peak time (T-max), peak concentration (C-max), area under the curve (AUC(0-12h)), apparent volume of distribution (V/F), and mean residence time (MRT) were significantly increased. Correlation coefficients between AUC(0-12h) and C-0/C-max were 0.894 and 0.916, respectively (both p<0.001). A serum creatinine (SCr)-based predictive C-0 equation [C-0=(2.160xSCr-54.473)xDose] was established and validated by C-0 from another 38 patients. Besides, significant linear correlations between k(el)/t(1/2) and CCr were also found (r(2)=0.668 and 0.484, respectively), and equations predicting k(el)/t(1/2) were also obtained (k(el)=0.015+0.002xCCr, t(1/2)=13.601-0.139xCCr).ConclusionsRenal function plays as an essential factor that contributes to great inter-individual MZR PK variation. Both C-0 and C-max are suitable for evaluating MZR exposure in the body. SCr could be applied to predict C-0 and t(1/2) of MZR.
引用
收藏
页码:363 / 369
页数:7
相关论文
共 50 条
  • [1] Prediction of mizoribine pharmacokinetic parameters by serum creatinine in renal transplant recipients
    Pan Chen
    Xuan Xu
    Longshan Liu
    Jingjing Wu
    Jingjie Li
    Qian Fu
    Jie Chen
    Changxi Wang
    European Journal of Clinical Pharmacology, 2019, 75 : 363 - 369
  • [2] Population Pharmacokinetic Analysis of Mizoribine in Chinese Renal Transplant Recipients
    Liu, L.
    Ren, B.
    Zhang, H.
    Li, J.
    Fu, Q.
    Jiang, J.
    Deng, S.
    Qiu, J.
    Chen, G.
    Fei, J.
    Chen, L.
    Wang, C.
    TRANSPLANTATION PROCEEDINGS, 2018, 50 (08) : 2392 - 2397
  • [3] POSTPRANDIAL INCREASE IN SERUM CREATININE IN RENAL-TRANSPLANT RECIPIENTS
    STERNER, G
    WROBLEWSKI, M
    ROSEN, U
    TRANSPLANT INTERNATIONAL, 1992, 5 (02) : 115 - 117
  • [4] Diagnostic Performance of Serum Cystatin C and Serum Creatinine in the Prediction of Chronic Kidney Disease in Renal Transplant Recipients
    Tsai, J-P.
    Wu, S-W.
    Hung, T-W.
    Kao, W-T.
    Hong, C-L.
    Lian, J-D.
    Chang, H-R.
    TRANSPLANTATION PROCEEDINGS, 2010, 42 (10) : 4530 - 4533
  • [5] Pregnancy and delivery in renal transplant recipients treated with mizoribine
    Yasumura, T
    Sagawa, S
    Akiyama, T
    Ichikawa, Y
    Ihara, H
    Kokado, Y
    Fukanishi, T
    Yoshimura, N
    Itoh, K
    Kurita, T
    Oka, T
    Sonoda, T
    JAPANESE JOURNAL OF TRANSPLANTATION, 1997, 32 (02) : 59 - 66
  • [6] Genetic and clinical determinants of mizoribine pharmacokinetics in renal transplant recipients
    Dai, Rui
    Li, Jingjie
    Wu, Jingjing
    Fu, Qian
    Yan, Jiajia
    Zhong, Guoping
    Wang, Changxi
    Chen, Xiao
    Chen, Pan
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 77 (01) : 45 - 53
  • [7] Genetic and clinical determinants of mizoribine pharmacokinetics in renal transplant recipients
    Rui Dai
    Jingjie Li
    Jingjing Wu
    Qian Fu
    Jiajia Yan
    Guoping Zhong
    Changxi Wang
    Xiao Chen
    Pan Chen
    European Journal of Clinical Pharmacology, 2021, 77 : 45 - 53
  • [8] Validation of serum creatinine-based formulae in pediatric renal transplant recipients
    Alkandari, Omar
    Hebert, Diane
    Langlois, Valerie
    Robinson, Lisa A.
    Parekh, Rulan S.
    PEDIATRIC RESEARCH, 2017, 82 (06) : 1000 - 1006
  • [9] Validation of serum creatinine-based formulae in pediatric renal transplant recipients
    Omar Alkandari
    Diane Hebert
    Valerie Langlois
    Lisa A Robinson
    Rulan S Parekh
    Pediatric Research, 2017, 82 : 1000 - 1006
  • [10] Prediction of tacrolimus and Wuzhi tablet pharmacokinetic interaction magnitude in renal transplant recipients
    Chen, Pan
    Dai, Rui
    She, Youjun
    Fu, Qian
    Huang, Min
    Chen, Xiao
    Wang, Changxi
    CLINICAL TRANSPLANTATION, 2022, 36 (12)